Jose Tafur Soto

Jose Tafur Soto

Auto-generated profile, based on publicly available information

Jose Tafur Soto

Department of Cardiology, Ochsner Clinic Foundation, LA, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
MPMarloe Prince
Marloe Prince
JTJose D. Tafur
Jose D. Tafur
CWChristopher J. White
Christopher J. White

1 August 2009 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
EAEberechi Patrick Akpaka
Eberechi Patrick Akpaka
WSWilliam H. Swanston
William H. Swanston
HIHyginus N. Ihemere
Hyginus N. Ihemere
ACAdriana Correa
Adriana Correa
JTJulian A. Torres
Julian A. Torres
MVMaria Virginia Villegas
Maria Virginia Villegas
In 2006, the first isolate of KPC-2-producing Pseudomonas aeruginosa in the world was identified in Colombia. Recently, similar strains have been reported in Puerto Rico. We now report KPC-2-producing P. aeruginosa in Trinidad and Tobago. Surveillance for similar strains is warranted, considering their wide geographic spread and known association with mobile genetic elements.

1 April 2017 in Current Problems in Cardiology
Verified
Journal Article
Closed access
JTJose D. Tafur
Jose D. Tafur
CWChristopher J. White
Christopher J. White

1 June 2020 in Integrated Blood Pressure Control
Verified
Journal Article
Open access
PDF file
RMRohini Manaktala
Rohini Manaktala
JTJose D Tafur-Soto
Jose D Tafur-Soto
CWChristopher J White
Christopher J White
Atherosclerosis is the primary cause of renal artery stenosis. Atherosclerotic renal artery stenosis (ARAS) is associated with three clinical problems: renovascular hypertension, ischemic nephropathy and cardiac destabilization syndrome which pose huge healthcare implications. There is a significant rate of natural disease progression with worsening severity of renal artery stenosis when renal revascularization is not pursued in a timely manner. Selective sub-groups of individuals with ARAS have had good outcomes after percutaneous renal artery stenting (PTRAS). For example, individuals that underwent PTRAS and had improved renal function were reported to have a 45% survival advantage compared to those without improvement in their renal function. Advances in the imaging tools have allowed for better anatomic and physiologic measurements of ARAS. Measuring translesional hemodynamic gradients has allowed for accurate assessment of ARAS severity. Renal revascularization with PTRAS provides a survival advantage in individuals with significant hemodynamic renal artery stenosis lesions. It is important that we screen, diagnosis, intervene with invasive and medical treatments appropriately in these high-risk patients.

1 February 2015 in Cardiology Clinics
Verified
Journal Article
Closed access
JTJose David Tafur-Soto
Jose David Tafur-Soto
CWChristopher J. White
Christopher J. White

1 May 2020 in Progress in Cardiovascular Diseases
Verified
Journal Article
Closed access
JPJustin Price
Justin Price
TBTamunoinemi Bob-Manuel
Tamunoinemi Bob-Manuel
JAJosh Aymond
Josh Aymond
OAOlayiwola Amoran
Olayiwola Amoran
HAHussain Almusawi
Hussain Almusawi
JTJose Tafur
Jose Tafur